BR112012019473A2 - compostos composição farmacêutica combinação de um composto uso de um composto e dispositivo - Google Patents

compostos composição farmacêutica combinação de um composto uso de um composto e dispositivo

Info

Publication number
BR112012019473A2
BR112012019473A2 BR112012019473A BR112012019473A BR112012019473A2 BR 112012019473 A2 BR112012019473 A2 BR 112012019473A2 BR 112012019473 A BR112012019473 A BR 112012019473A BR 112012019473 A BR112012019473 A BR 112012019473A BR 112012019473 A2 BR112012019473 A2 BR 112012019473A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
composition combination
combination
compound use
Prior art date
Application number
BR112012019473A
Other languages
English (en)
Inventor
Rizzi Andrea
Virdis Andrea
Rencurosi Anna
Ghidini Eleonora
Rancati Fabio
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of BR112012019473A2 publication Critical patent/BR112012019473A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0052—Nitrogen only at position 16(17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112012019473A 2010-02-05 2011-02-03 compostos composição farmacêutica combinação de um composto uso de um composto e dispositivo BR112012019473A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10152731 2010-02-05
PCT/EP2011/051537 WO2011095535A2 (en) 2010-02-05 2011-02-03 Pyrrolidine derivatives

Publications (1)

Publication Number Publication Date
BR112012019473A2 true BR112012019473A2 (pt) 2019-09-24

Family

ID=42244408

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012019473A BR112012019473A2 (pt) 2010-02-05 2011-02-03 compostos composição farmacêutica combinação de um composto uso de um composto e dispositivo

Country Status (10)

Country Link
US (1) US8481517B2 (pt)
EP (1) EP2531516A2 (pt)
KR (1) KR20120116462A (pt)
CN (1) CN102741268A (pt)
AR (1) AR080139A1 (pt)
BR (1) BR112012019473A2 (pt)
CA (1) CA2788986A1 (pt)
RU (1) RU2012133250A (pt)
TW (1) TW201139369A (pt)
WO (1) WO2011095535A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013022890A2 (pt) 2011-03-15 2016-09-13 Chiesi Farma Spa composto, composição farmacêutica, combinação e uso de um composto
WO2012123482A2 (en) 2011-03-15 2012-09-20 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
CA2843782A1 (en) * 2011-08-01 2013-02-07 Chiesi Farmaceutici S.P.A. Anti-inflammatory steroids condensed in position 16,17 with pyrrolidine ring
US9155747B2 (en) 2012-09-13 2015-10-13 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
CN108659084A (zh) * 2017-03-31 2018-10-16 天津药业研究院有限公司 一种17β-羧酸氯甲酯类甾体化合物的制备方法
CN108659083A (zh) * 2017-03-31 2018-10-16 天津药业研究院有限公司 一种依碳氯替泼诺的合成方法
CN112142820A (zh) * 2019-06-29 2020-12-29 天津药业研究院股份有限公司 曲安奈德的合成方法
IL304059A (en) * 2021-01-07 2023-08-01 Immunext Inc New steroid fillers, steroid binders and drug antibody conjugates containing them and use
CN115785188B (zh) * 2022-12-20 2024-06-07 湖南科益新生物医药有限公司 一种布地奈德的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2838545A (en) 1958-02-19 1958-06-10 Upjohn Co 6 alpha-fluoro-16 alpha-hydroxy steroids
US2864838A (en) 1958-02-19 1958-12-16 Upjohn Co 6 methyl 16 oxy delta4 pregnenes and delta1, 4 pregnadienes
US4018774A (en) * 1976-02-13 1977-04-19 E. R. Squibb & Sons, Inc. Steroidal [16α,17-d]isoxazolidines
US4018757A (en) * 1976-05-20 1977-04-19 E. R. Squibb & Sons, Inc. Steroidal[16α,17-c][2H]pyrroles
US4474702A (en) * 1984-01-20 1984-10-02 E. R. Squibb & Sons, Inc. [16,17-a]Cyclopentano pregnenes
GB0415747D0 (en) * 2004-07-14 2004-08-18 Novartis Ag Organic compounds
WO2009069032A2 (en) 2007-11-30 2009-06-04 Pfizer Limited Novel glucocorticoid receptor agonists
ME01331B (me) 2009-09-11 2013-12-20 Chiesi Farm Spa Derivati izoksazolidina

Also Published As

Publication number Publication date
RU2012133250A (ru) 2014-02-10
AR080139A1 (es) 2012-03-14
TW201139369A (en) 2011-11-16
US20110201580A1 (en) 2011-08-18
CA2788986A1 (en) 2011-08-11
KR20120116462A (ko) 2012-10-22
CN102741268A (zh) 2012-10-17
WO2011095535A3 (en) 2011-11-17
EP2531516A2 (en) 2012-12-12
WO2011095535A2 (en) 2011-08-11
US8481517B2 (en) 2013-07-09

Similar Documents

Publication Publication Date Title
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013015397A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014001255A2 (pt) composto, uso de um composto, combinação, e, composição farmacêutica
BR112013030302A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
BR112014013760A2 (pt) composto, composição farmacêutica e uso de um composto
BRPI1008793A2 (pt) composto, uso de um composto, e, composição farmacêutica
BRPI1016219A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112015000420A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014029530A2 (pt) compostos, composição farmacêutica e uso de um composto
BR112014005669A2 (pt) composto, composição farmacêutica e uso de um composto
BR112014029115A2 (pt) composto, composição farmacêutica, e, uso de um composto ou composição
BR112012013148A2 (pt) formulação farmacêutica e uso
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BR112014003567A2 (pt) composto, uso de um composto, e, composição farmacêutica
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112012019473A2 (pt) compostos composição farmacêutica combinação de um composto uso de um composto e dispositivo
BR112014009471A2 (pt) compostos, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112014029642A2 (pt) composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BR112013010988A2 (pt) composição fluída e uso
BR112014013177A2 (pt) composto, composição farmacêutica e uso de um composto
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BR112014013178A2 (pt) composto, composição farmacêutica e uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.